No single ticker was named. Biotech ETFs are one way for retail investors to get exposure. Not a recommendation.
China leads US in early-stage biotech trials
The speaker argued that China is rapidly outpacing the US in biotech innovation by establishing an efficient, high-speed clinical trial infrastructure for first-in-human studies.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.